Human Diagnostics
Comprehensive and accurate human diagnostic results from a single sample
Achieve optimum diagnostic results across a wide range of conditions in different research areas and industries.
MT-PCR panels utilise patented RIDA®Plex technology to provide unmatched multiplexing capability, allowing efficient and comprehensive testing of over 40 genetics markers from a single sample.
Dermatophytes
R-Biopharm offers advanced dermatology diagnostics for rapid, reliable detection of dermatophytes, yeasts, and moulds from skin, hair, and nail specimens. Powered by multiplex tandem PCR (MT-PCR), these panels deliver accurate results within hours, enabling faster diagnosis and treatment. Fully compatible with R-Biopharm platforms, they provide laboratories with efficient, streamlined tools to improve workflows and support better patient outcomes.
Gastrointestinal
R-Biopharm Australia provides a comprehensive range of gastrointestinal diagnostic assays designed for the rapid, reliable detection of bacterial, parasitic, helminthic, and viral pathogens. Using advanced multiplex technology, our panels streamline the identification of complex infections by combining multiple targets into a single test, reducing time and sample handling. With IVD-compliant solutions optimised for high-throughput laboratories, we deliver accuracy, efficiency, and confidence.
Respiratory Pathogens
R-Biopharm offers a comprehensive range of diagnostic solutions for respiratory infections, utilising advanced multiplex tandem PCR (MT-PCR) technology. Our RIDA®Plex panels enable the qualitative detection of multiple pathogens, including SARS-CoV-2 and Influenza A & B. These panels are designed for professional use in clinical laboratories, providing rapid and accurate results to support effective patient management.
Hospital Care
R-Biopharm Australia offers a powerful suite of molecular diagnostics for hospital care and antimicrobial resistance, enabling rapid, multiplexed detection of critical resistance markers. With IVD-compliant RIDAPlex® panels developed for high-throughput clinical labs, our solutions simplify the complex landscape of nosocomial pathogens and support better antimicrobial stewardship by delivering fast, accurate, clinically actionable results.
Drug Resistance
R-Biopharm Australia offers a powerful suite of molecular diagnostics for hospital care and antimicrobial resistance, enabling rapid, multiplexed detection of critical resistance markers. With IVD-compliant RIDAPlex® panels developed for high-throughput clinical labs, our solutions simplify the complex landscape of nosocomial pathogens and support better antimicrobial stewardship by delivering fast, accurate, clinically actionable results.
Sexual Health
R-Biopharm Australia delivers advanced multiplexed molecular assays for sexual health and dermatology, enabling simultaneous detection of sexually transmitted infections, pathogenic flora, and antimicrobial resistance markers from a single sample. Utilising MT-PCR RIDA®Plex panels, our solutions offer high sensitivity and specificity, streamline diagnostic workflows, and support informed treatment decisions—empowering laboratories to deliver rapid, reliable results.
Urinary Tract Infections
Our urinary tract infections solutions removes the need for DNA/RNA purification, delivering a rapid, 20-minute protocol with minimal manual handling. It’s applicable across bacterial, yeast, and protozoan pathogens, with efficient processing that neutralises PCR inhibitors. Automated sampling managed via the MT-PCR Assay Setup software streamlines your work ow while preserving sensitivity and accuracy.
Women’s Health
Our Women’s Health solution dispenses with the need for DNA/RNA purification and delivers a swift 20-minute protocol with minimal hands-on steps. It’s suited for detecting a spectrum of bacterial, viral, fungal, and protozoan targets, while our streamlined specimen processing efficiently mitigates PCR inhibitors. With automated sampling from RIDA®PrepX tubes via MT-PCR Assay Setup software, the workflow is seamless, robust and clinically reliable.
Vector-Borne Infections
Our vector-borne disease solution removes the need for DNA/RNA purification and delivers a rapid 20-minute protocol with minimal manual intervention. It supports viral, bacterial, and protozoan parasite targets, including dengue, Zika, Ross River, West Nile, Plasmodium spp., and more, with built-in detection of artemisinin resistance. Streamlined specimen processing neutralises PCR inhibitors, and automated sampling from RIDA®PrepX tubes via MT-PCR Assay Setup software ensures speed, efficiency, and diagnostic confidence.
